ACADIA Pharmaceuticals Market Cap:
1.119B for May 20, 2013ACADIA Pharmaceuticals Historical Market Cap Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| May 20, 2013 | 1.119B |
| May 17, 2013 | 1.051B |
| May 16, 2013 | 1.030B |
| May 15, 2013 | 1.033B |
| May 14, 2013 | 1.025B |
| May 13, 2013 | 1.005B |
| May 10, 2013 | 951.56M |
| May 9, 2013 | 944.44M |
| May 8, 2013 | 922.27M |
| May 7, 2013 | 952.35M |
| May 6, 2013 | 964.23M |
| May 3, 2013 | 977.69M |
| May 2, 2013 | 976.10M |
| May 1, 2013 | 951.56M |
| April 30, 2013 | 1.020B |
| April 29, 2013 | 1.044B |
| April 26, 2013 | 984.31M |
| April 25, 2013 | 982.18M |
| April 24, 2013 | 990.92M |
| April 23, 2013 | 995.33M |
| April 22, 2013 | 965.95M |
| April 19, 2013 | 888.08M |
| April 18, 2013 | 894.69M |
| April 17, 2013 | 904.98M |
| April 16, 2013 | 910.12M |
| April 15, 2013 | 893.22M |
| April 12, 2013 | 921.14M |
| April 11, 2013 | 962.27M |
| April 10, 2013 | 585.44M |
| April 9, 2013 | 582.51M |
| April 8, 2013 | 586.18M |
| April 5, 2013 | 565.61M |
| April 4, 2013 | 564.88M |
| April 3, 2013 | 557.53M |
| April 2, 2013 | 569.28M |
| April 1, 2013 | 580.30M |
| March 28, 2013 | 625.34M |
| March 27, 2013 | 638.73M |
| March 26, 2013 | 648.10M |
| March 25, 2013 | 654.48M |
| March 22, 2013 | 596.20M |
| March 21, 2013 | 648.97M |
| March 20, 2013 | 523.74M |
| March 19, 2013 | 518.23M |
| March 18, 2013 | 486.72M |
| March 15, 2013 | 493.03M |
| March 14, 2013 | 503.26M |
| March 13, 2013 | 479.64M |
| March 12, 2013 | 496.96M |
| March 11, 2013 | 510.35M |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
ACAD Market Cap Benchmarks
| Companies | |
|---|---|
| Insmed | 346.57M |
| Sarepta Therapeutics | 1.175B |
| Exelixis | 836.30M |
ACAD Market Cap Rankings
| Overall |
74th percentile 2034 of 8002 |
| Sector |
73rd percentile 171 of 650 in Healthcare |
| Industry |
82nd percentile 42 of 237 in Biotechnology |
ACAD Market Cap Range, Past 5 Years
| Minimum | 25.94M | Nov 12 2010 |
| Maximum | 1.119B | May 20 2013 |
| Average | 122.68M |
